Literature DB >> 26228470

Threshold levels of visual field and acuity loss related to significant decreases in the quality of life and emotional states of patients with retinitis pigmentosa.

Line Azoulay1, Philippe Chaumet-Riffaud, Steven Jaron, Camille Roux, Serge Sancho, Naomi Berdugo, Isabelle Audo, José-Alain Sahel, Saddek Mohand-Saïd.   

Abstract

INTRODUCTION: Retinitis pigmentosa (RP) is an inherited retinal disorder, characterized by photoreceptor degeneration inducing progressive vision loss. This study evaluates its impact on quality of life (QOL) and emotional states of patients affected by RP.
METHODS: A cross-sectional study was conducted on 60 RP patients diagnosed with rod-cone dystrophy and on 20 control subjects. The RP population has been divided into 3 groups according to visual field (VF) and visual acuity (VA) impairments. Concurrently, scores of self-reported QOL (25-item National Eye Institute Visual Functioning Questionnaire) and of the Hospital Anxiety and Depression Scale for anxiety/depression assessments were collected.
RESULTS: For the QOL composite score, we noticed consistent differences between all VF and VA affected groups and their control group. We also found significant differences between both the most affected VF group (VF1: ØVF <20°) and VA group (VA1: VA <0.3) compared to other VF and VA groups. For anxiety/depression scores, consistent differences have been found between the control group and VF1 and VA1, respectively.
CONCLUSIONS: This work determines that, for RP patients, a significant QOL and emotional state deterioration correlates with a residual VF diameter below 20° and a VA lower than 0.3. It introduces, for the first time, thresholds to be used in visual restoration or visual preservation therapies to improve QOL of RP patients.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 26228470     DOI: 10.1159/000435886

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  11 in total

1.  CHOROIDEREMIA: Retinal Degeneration With an Unmet Need.

Authors:  Mark E Pennesi; David G Birch; Jacque L Duncan; Jean Bennett; Aniz Girach
Journal:  Retina       Date:  2019-11       Impact factor: 4.256

2.  The Michigan Vision-Related Anxiety Questionnaire: A Psychosocial Outcomes Measure for Inherited Retinal Degenerations.

Authors:  Gabrielle D Lacy; Maria Fernanda Abalem; Chris A Andrews; Rebhi Abuzaitoun; Lilia T Popova; Erin P Santos; Gina Yu; Hanan Y Rakine; Natasha Baig; Joshua R Ehrlich; Abigail T Fahim; Kari H Branham; Bonnielin K Swenor; Paul R Lichter; Gislin Dagnelie; Joan A Stelmack; David C Musch; K Thiran Jayasundera
Journal:  Am J Ophthalmol       Date:  2020-12-09       Impact factor: 5.258

3.  Longitudinal Vision-Related Quality of Life for Patients with Noninfectious Uveitis Treated with Fluocinolone Acetonide Implant or Systemic Corticosteroid Therapy.

Authors:  Elizabeth A Sugar; Vidya Venugopal; Jennifer E Thorne; Kevin D Frick; Gary N Holland; Robert C Wang; Robert Almanzor; Douglas A Jabs; Janet T Holbrook
Journal:  Ophthalmology       Date:  2017-06-16       Impact factor: 14.277

4.  Baseline Visual Field Findings in the RUSH2A Study: Associated Factors and Correlation With Other Measures of Disease Severity.

Authors:  Jacque L Duncan; Wendi Liang; Maureen G Maguire; Isabelle Audo; Allison R Ayala; David G Birch; Joseph Carroll; Janet K Cheetham; Simona Degli Esposti; Todd A Durham; Laura Erker; Sina Farsiu; Frederick L Ferris; Elise Heon; Robert B Hufnagel; Alessandro Iannaccone; Glenn J Jaffe; Christine N Kay; Michel Michaelides; Mark E Pennesi; José-Alain Sahel
Journal:  Am J Ophthalmol       Date:  2020-05-22       Impact factor: 5.488

5.  Emotional Health of People with Visual Impairment Caused by Retinitis Pigmentosa.

Authors:  Keziah Latham; Mohammad Baranian; Matthew Timmis; Shahina Pardhan
Journal:  PLoS One       Date:  2015-12-29       Impact factor: 3.240

6.  Quantitative analyses of factors related to anxiety and depression in patients with retinitis pigmentosa.

Authors:  Mayumi Sainohira; Takehiro Yamashita; Hiroto Terasaki; Shozo Sonoda; Kazunori Miyata; Yusuke Murakami; Yasuhiro Ikeda; Takeshi Morimoto; Takao Endo; Takashi Fujikado; Junko Kamo; Taiji Sakamoto
Journal:  PLoS One       Date:  2018-04-23       Impact factor: 3.240

7.  Validation of a vision-related activity scale for patients with retinitis pigmentosa.

Authors:  Francisco M Costela; Konrad Pesudovs; Michael A Sandberg; Carol Weigel-DiFranco; Russell L Woods
Journal:  Health Qual Life Outcomes       Date:  2020-06-22       Impact factor: 3.186

8.  Vision-related quality of life in adults with severe peripheral vision loss: a qualitative interview study.

Authors:  Ryan Lange; Abigail Kumagai; Sara Weiss; Katherine B Zaffke; Sherry Day; Donna Wicker; Ashley Howson; K Thiran Jayasundera; Lori Smolinski; Christina Hedlich; Paul P Lee; Robert W Massof; Joan A Stelmack; Noelle E Carlozzi; Joshua R Ehrlich
Journal:  J Patient Rep Outcomes       Date:  2021-01-13

9.  Altered White Matter Integrity in Patients with Retinal Vein Occlusion: A Diffusion Tensor Imaging and Tract-Based Spatial Statistics Study.

Authors:  Mou-Xin Zhang; Min-Jie Chen; Li-Ying Tang; Chen-Yu Yu; Yu-Ling Xu; San-Hua Xu; Ping Ying; Min Kang; Li-Juan Zhang; Yi Shao
Journal:  Dis Markers       Date:  2022-02-24       Impact factor: 3.434

Review 10.  The Burden of X-Linked Retinitis Pigmentosa on Patients and Society: A Narrative Literature Review.

Authors:  Marie Chivers; Nan Li; Feng Pan; Heather Wieffer; Rafal Slowik; Jittrakul Leartsakulpanitch
Journal:  Clinicoecon Outcomes Res       Date:  2021-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.